Published in Inorg Chem on October 13, 2010
Investigating chelating sulfonamides and their use in metalloproteinase inhibitors. Dalton Trans (2012) 0.78
Small-molecule fluorescent sensors for investigating zinc metalloneurochemistry. Acc Chem Res (2009) 2.07
In situ imaging of metals in cells and tissues. Chem Rev (2009) 2.03
Zinc(II)-selective ratiometric fluorescent sensors based on inhibition of excited-state intramolecular proton transfer. Chemistry (2004) 1.12
The chemical cell biology of zinc: structure and intracellular fluorescence of a zinc-quinolinesulfonamide complex. J Biol Inorg Chem (1999) 1.07
DNA interaction of new copper(II) complexes with sulfonamides as ligands. J Inorg Biochem (2006) 1.00
From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases. J Am Chem Soc (2010) 0.97
Fluorescent nitric oxide detection by copper complexes bearing anthracenyl and dansyl fluorophore ligands. Inorg Chem (2006) 0.92
Nitric oxide-induced fluorescence enhancement by displacement of dansylated ligands from cobalt. Chembiochem (2006) 0.83
Crystal structure of [Cu(N-quinolin-8-yl-p-toluenesulfonamidate)(2)]: study of its interaction with DNA and hydrogen peroxide. J Inorg Biochem (2002) 0.82
Clinical practice guideline: hoarseness (dysphonia). Otolaryngol Head Neck Surg (2009) 2.31
Brilliant Sm, Eu, Tb, and Dy chiral lanthanide complexes with strong circularly polarized luminescence. J Am Chem Soc (2007) 2.14
Postsynthetic modification of metal-organic frameworks. Chem Soc Rev (2009) 1.93
Stable lanthanide luminescence agents highly emissive in aqueous solution: multidentate 2-hydroxyisophthalamide complexes of Sm(3+), Eu(3+), Tb(3+), Dy(3+). J Am Chem Soc (2003) 1.91
To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta (2009) 1.48
Zinc-binding groups modulate selective inhibition of MMPs. ChemMedChem (2008) 1.47
New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups. J Am Chem Soc (2004) 1.46
The design of inhibitors for medicinally relevant metalloproteins. ChemMedChem (2007) 1.44
Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg (2007) 1.41
Postsynthetic modification of metal-organic frameworks--a progress report. Chem Soc Rev (2010) 1.40
Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors. Inorg Chem (2003) 1.35
Hydrogen peroxide activated matrix metalloproteinase inhibitors: a prodrug approach. Angew Chem Int Ed Engl (2010) 1.29
Potent, selective pyrone-based inhibitors of stromelysin-1. J Am Chem Soc (2005) 1.28
Metal binding studies and EPR spectroscopy of the manganese transport regulator MntR. Biochemistry (2006) 1.28
Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma. J Clin Invest (2005) 1.24
A bioinorganic perspective on matrix metalloproteinase inhibition. Curr Top Med Chem (2004) 1.18
Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity. J Biol Inorg Chem (2005) 1.17
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. J Med Chem (2010) 1.15
A new role for old ligands: discerning chelators for zinc metalloproteinases. J Am Chem Soc (2006) 1.13
Postsynthetic ligand and cation exchange in robust metal-organic frameworks. J Am Chem Soc (2012) 1.08
Evaluation and binding-mode prediction of thiopyrone-based inhibitors of anthrax lethal factor. ChemMedChem (2006) 1.05
Characterization and structure of the manganese-responsive transcriptional regulator ScaR. Biochemistry (2009) 1.04
Thioamide hydroxypyrothiones supersede amide hydroxypyrothiones in potency against anthrax lethal factor. J Med Chem (2009) 1.04
Chelator fragment libraries for targeting metalloproteinases. ChemMedChem (2010) 1.02
Investigating the selectivity of metalloenzyme inhibitors. J Med Chem (2013) 0.99
2.4-A crystal structure of the asymmetric platinum complex [Pt(ammine)(cyclohexylamine)]2+ bound to a dodecamer DNA duplex. J Biol Chem (2002) 0.99
Metal-induced structural organization and stabilization of the metalloregulatory protein MntR. Biochemistry (2005) 0.98
Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors. Chem Commun (Camb) (2011) 0.98
DNA-binding and oligomerization studies of the manganese(II) metalloregulatory protein MntR from Bacillus subtilis. Biochemistry (2003) 0.98
Moisture-resistant and superhydrophobic metal-organic frameworks obtained via postsynthetic modification. J Am Chem Soc (2010) 0.97
From sensors to silencers: quinoline- and benzimidazole-sulfonamides as inhibitors for zinc proteases. J Am Chem Soc (2010) 0.97
Using model complexes to augment and advance metalloproteinase inhibitor design. Inorg Chem (2004) 0.96
Postsynthetic covalent modification of a neutral metal-organic framework. J Am Chem Soc (2007) 0.95
Systematic functionalization of a metal-organic framework via a postsynthetic modification approach. J Am Chem Soc (2008) 0.94
Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. J Am Chem Soc (2006) 0.94
Squamous cell carcinoma of the oropharynx and hypopharynx. Otolaryngol Clin North Am (2005) 0.93
Postsynthetic modification: a versatile approach toward multifunctional metal-organic frameworks. Inorg Chem (2009) 0.92
Enantiopure vs. racemic metalloligands: impact on metal-organic framework structure and synthesis. Chem Commun (Camb) (2007) 0.92
Accessing postsynthetic modification in a series of metal-organic frameworks and the influence of framework topology on reactivity. Inorg Chem (2009) 0.92
Addressing lead toxicity: complexation of lead(II) with thiopyrone and hydroxypyridinethione O,S mixed chelators. Inorg Chem (2004) 0.92
Enzymatic activation of a matrix metalloproteinase inhibitor. Chem Commun (Camb) (2010) 0.91
Observing the growth of metal-organic frameworks by in situ liquid cell transmission electron microscopy. J Am Chem Soc (2015) 0.91
A chiral, heterometallic metal-organic framework derived from a tris(chelate) coordination complex. Chem Commun (Camb) (2005) 0.90
Conformational studies of the manganese transport regulator (MntR) from Bacillus subtilis using deuterium exchange mass spectrometry. J Biol Inorg Chem (2007) 0.90
Compliance and quality of life in patients on prescribed voice rest. Otolaryngol Head Neck Surg (2011) 0.90
Emerging trends in metalloprotein inhibition. Dalton Trans (2011) 0.89
A novel heterocyclic atom exchange reaction with Lawesson's reagent: a one-pot synthesis of dithiomaltol. Chem Commun (Camb) (2005) 0.89
Engineering a metal-organic framework catalyst by using postsynthetic modification. Angew Chem Int Ed Engl (2009) 0.89
Tandem modification of metal-organic frameworks by a postsynthetic approach. Angew Chem Int Ed Engl (2008) 0.88
Preparation techniques for the injection of human autologous cartilage: an ex vivo feasibility study. Laryngoscope (2008) 0.88
Antagonism of a zinc metalloprotease using a unique metal-chelating scaffold: tropolones as inhibitors of P. aeruginosa elastase. Chem Commun (Camb) (2013) 0.88
Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes. Inorg Chem (2002) 0.88
Metal complexes of the trans-influencing ligand thiomaltol. Inorg Chem (2003) 0.88
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors. Chem Commun (Camb) (2012) 0.88
From model complexes to metalloprotein inhibition: a synergistic approach to structure-based drug discovery. Angew Chem Int Ed Engl (2003) 0.87
Probing chelation motifs in HIV integrase inhibitors. Proc Natl Acad Sci U S A (2012) 0.87
Isoreticular synthesis and modification of frameworks with the UiO-66 topology. Chem Commun (Camb) (2010) 0.87
Activation of sulfonate ester based matrix metalloproteinase proinhibitors by hydrogen peroxide. J Biol Inorg Chem (2010) 0.85
3-Hydroxy-1-alkyl-2-methylpyridine-4(1H)-thiones: Inhibition of the Pseudomonas aeruginosa Virulence Factor LasB. ACS Med Chem Lett (2012) 0.85
Synthesis, structure and spectroscopy of new thiopyrone and hydroxypyridinethione transition-metal complexes. Dalton Trans (2005) 0.84
A macrophage cell model for selective metalloproteinase inhibitor design. Chembiochem (2008) 0.83
Enhanced photochemical hydrogen production by a molecular diiron catalyst incorporated into a metal-organic framework. J Am Chem Soc (2013) 0.83
Modulating metal-organic frameworks to breathe: a postsynthetic covalent modification approach. J Am Chem Soc (2009) 0.83
Generating reactive MILs: isocyanate- and isothiocyanate-bearing MILs through postsynthetic modification. Angew Chem Int Ed Engl (2010) 0.83
Topological control in heterometallic metal-organic frameworks by anion templating and metalloligand design. J Am Chem Soc (2006) 0.83
Reusable oxidation catalysis using metal-monocatecholato species in a robust metal-organic framework. J Am Chem Soc (2014) 0.83
Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases. Org Lett (2007) 0.82
Use of AlloDerm in type I tympanoplasty: a comparison with native tissue grafts. Laryngoscope (2005) 0.82
Covalent modification of a metal-organic framework with isocyanates: probing substrate scope and reactivity. Chem Commun (Camb) (2008) 0.82
Tuning the adsorption properties of UiO-66 via ligand functionalization. Langmuir (2012) 0.81
Evaluating prodrug strategies for esterase-triggered release of alcohols. ChemMedChem (2013) 0.81
Photochemical activation of a metal-organic framework to reveal functionality. Angew Chem Int Ed Engl (2010) 0.81
Model complexes of cobalt-substituted matrix metalloproteinases: tools for inhibitor design. Inorg Chem (2006) 0.81
Tandem postsynthetic modification of metal-organic frameworks using an inverse-electron-demand Diels-Alder reaction. Inorg Chem (2011) 0.81
Photocatalytic CO2 reduction by a mixed metal (Zr/Ti), mixed ligand metal-organic framework under visible light irradiation. Chem Commun (Camb) (2015) 0.80
Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry. ChemMedChem (2010) 0.80
Luminescent dipyrrinato complexes of trivalent group 13 metal ions. Inorg Chem (2006) 0.80
Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship. Bioorg Med Chem Lett (2009) 0.80
A robust, catalytic metal-organic framework with open 2,2'-bipyridine sites. Chem Commun (Camb) (2014) 0.80
Evaluation of heterogeneous metal-organic framework organocatalysts prepared by postsynthetic modification. Inorg Chem (2010) 0.79
Preparation and characterization of asymmetric alpha-alkoxy dipyrrin ligands and their metal complexes. Dalton Trans (2007) 0.79
Synthesis, breathing, and gas sorption study of the first isoreticular mixed-linker phosphonate based metal-organic frameworks. Chem Commun (Camb) (2013) 0.79
'Unconventional' coordination chemistry by metal chelating fragments in a metalloprotein active site. J Am Chem Soc (2014) 0.79
Metalloprotein-inhibitor binding: human carbonic anhydrase II as a model for probing metal-ligand interactions in a metalloprotein active site. Inorg Chem (2013) 0.79
Heterometallic metal-organic frameworks based on tris(dipyrrinato) coordination complexes. Inorg Chem (2005) 0.78
Self-assembly of heteroleptic [Cu(dipyrrinato)(hfacac)] complexes directed by fluorine-fluorine interactions. Inorg Chem (2005) 0.78
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation. Cancer (2013) 0.78
Role of rhinitis in laryngitis: another dimension of the unified airway. Ann Otol Rhinol Laryngol (2011) 0.78
Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity. Bioorg Med Chem (2008) 0.78
Investigating chelating sulfonamides and their use in metalloproteinase inhibitors. Dalton Trans (2012) 0.78
Modular, active, and robust Lewis acid catalysts supported on a metal-organic framework. Inorg Chem (2010) 0.78
Heteroleptic copper dipyrromethene complexes: synthesis, structure, and coordination polymers. Inorg Chem (2004) 0.78
Targeting metalloproteins by fragment-based lead discovery. Chem Biol Drug Des (2011) 0.78
Tuning hydrogen sorption properties of metal-organic frameworks by postsynthetic covalent modification. Chemistry (2010) 0.78
Metalation of a thiocatechol-functionalized Zr(IV)-based metal-organic framework for selective C-H functionalization. J Am Chem Soc (2015) 0.77
Tandem postsynthetic metal ion and ligand exchange in zeolitic imidazolate frameworks. Inorg Chem (2013) 0.77
Hypopharyngeal surgery in obstructive sleep apnea: practice patterns, perceptions, and attitudes. Otolaryngol Head Neck Surg (2012) 0.77
Diamidodipyrrins: versatile bipyrrolic ligands with multiple metal binding modes. Inorg Chem (2008) 0.77